Journal of Molecular Endocrinology

References

1. ↵
   1. Ali S,
   2. Chen X,
   3. Lu M,
   4. Xu JZ,
   5. Lerea KM,
   6. Hebert SC &
   7. Wang WH

   1998 The A kinase anchoring protein is required for mediating the effect of protein kinase A on ROMK1 channels. PNAS 95 10274–10278.
2. ↵
   1. Alto NM,
   2. Soderling SH,
   3. Hoshi N,
   4. Langeberg LK,
   5. Fayos R,
   6. Jennings PA &
   7. Scott JD

   2003 Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring. PNAS 100 4445–4450.
3. ↵
   1. Baillie GS,
   2. Scott JD &
   3. Houslay MD

   2005 Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Letters 579 3264–3270.
4. ↵
   1. Banky P,
   2. Huang LJ &
   3. Taylor SS

   1998 Dimerization/docking domain of the type Iα regulatory subunit of cAMP-dependent protein kinase. Requirements for dimerization and docking are distinct but overlapping. Journal of Biological Chemistry 273 35048–35055.
5. ↵
   1. Banky P,
   2. Newlon MG,
   3. Roy M,
   4. Garrod S,
   5. Taylor SS &
   6. Jennings PA

   2000 Isoform-specific differences between the type Iα and IIalpha cyclic AMP-dependent protein kinase anchoring domains revealed by solution NMR. Journal of Biological Chemistry 275 35146–35152.
6. ↵
   1. Banky P,
   2. Roy M,
   3. Newlon MG,
   4. Morikis D,
   5. Haste NM,
   6. Taylor SS &
   7. Jennings PA

   2003 Related protein–protein interaction modules present drastically different surface topographies despite a conserved helical platform. Journal of Molecular Biology 330 1117–1129.
7. ↵
   1. Beene DL &
   2. Scott JD

   2007 A-kinase anchoring proteins take shape. Current Opinion in Cell Biology 19 192–198.
8. ↵
   1. Biel M

   2009 Cyclic nucleotide-regulated cation channels. Journal of Biological Chemistry 284 9017–9021.
9. ↵
   1. Bos JL

   2006 Epac proteins: multi-purpose cAMP targets. Trends in Biochemical Sciences 31 680–686.
10. ↵
    1. Burns-Hamuro LL,
    2. Ma Y,
    3. Kammerer S,
    4. Reineke U,
    5. Self C,
    6. Cook C,
    7. Olson GL,
    8. Cantor CR,
    9. Braun A &
    10. Taylor SS

    2003 Designing isoform-specific peptide disruptors of protein kinase A localization. PNAS 100 4072–4077.
11. ↵
    1. Cadd G &
    2. McKnight GS

    1989 Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain. Neuron 3 71–79.
12. ↵
    1. Cadd GG,
    2. Uhler MD &
    3. McKnight GS

    1990 Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides. Journal of Biological Chemistry 265 19502–19506.
13. ↵
    1. Canaves JM &
    2. Taylor SS

    2002 Classification and phylogenetic analysis of the cAMP-dependent protein kinase regulatory subunit family. Journal of Molecular Evolution 54 17–29.
14. ↵
    1. Carlson CR,
    2. Lygren B,
    3. Berge T,
    4. Hoshi N,
    5. Wong W,
    6. Tasken K &
    7. Scott JD

    2006 Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. Journal of Biological Chemistry 281 21535–21545.
15. ↵
    1. Carnegie GK &
    2. Scott JD

    2003 A-kinase anchoring proteins and neuronal signaling mechanisms. Genes and Development 17 1557–1568.
16. ↵
    1. Carr DW,
    2. Stofko-Hahn RE,
    3. Fraser ID,
    4. Bishop SM,
    5. Acott TS,
    6. Brennan RG &
    7. Scott JD

    1991 Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif. Journal of Biological Chemistry 266 14188–14192.
17. ↵
    1. Carr DW,
    2. Hausken ZE,
    3. Fraser ID,
    4. Stofko-Hahn RE &
    5. Scott JD

    1992 Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain. Journal of Biological Chemistry 267 13376–13382.
18. ↵
    1. Chen L,
    2. Marquardt ML,
    3. Tester DJ,
    4. Sampson KJ,
    5. Ackerman MJ &
    6. Kass RS

    2007 Mutation of an A-kinase-anchoring protein causes long-QT syndrome. PNAS 104 20990–20995.
19. ↵
    1. Clegg CH,
    2. Cadd GG &
    3. McKnight GS

    1988 Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase. PNAS 85 3703–3707.
20. ↵
    1. Coghlan VM,
    2. Perrino BA,
    3. Howard M,
    4. Langeberg LK,
    5. Hicks JB,
    6. Gallatin WM &
    7. Scott JD

    1995 Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267 108–111.
21. ↵
    1. Colledge M &
    2. Scott JD

    1999 AKAPs: from structure to function. Trends in Cell Biology 9 216–221.
22. ↵
    1. Conti M &
    2. Beavo J

    2007 Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annual Review of Biochemistry 76 481–511.
23. ↵
    1. Conti M &
    2. Jin SL

    1999 The molecular biology of cyclic nucleotide phosphodiesterases. Progress in Nucleic Acid Research and Molecular Biology 63 1–38.
24. ↵
    1. Cooper DM

    2003 Regulation and organization of adenylyl cyclases and cAMP. Biochemical Journal 375 517–529.
25. ↵
    1. Corbin JD &
    2. Keely SL

    1977 Characterization and regulation of heart adenosine 3′:5′-monophosphate-dependent protein kinase isozymes. Journal of Biological Chemistry 252 910–918.
26. ↵
    1. Corbin JD,
    2. Soderling TR &
    3. Park CR

    1973 Regulation of adenosine 3′,5′-monophosphate-dependent protein kinase. I. Preliminary characterization of the adipose tissue enzyme in crude extracts. Journal of Biological Chemistry 248 1813–1821.
27. ↵
    1. Corbin JD,
    2. Keely SL &
    3. Park CR

    1975 The distribution and dissociation of cyclic adenosine 3′:5′-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues. Journal of Biological Chemistry 250 218–225.
28. ↵
    1. De Rooij J,
    2. Zwartkruis FJ,
    3. Verheijen MH,
    4. Cool RH,
    5. Nijman SM,
    6. Wittinghofer A &
    7. Bos JL

    1998 Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 474–477.
29. ↵
    1. Diviani D &
    2. Scott JD

    2001 AKAP signaling complexes at the cytoskeleton. Journal of Cell Science 114 1431–1437.
30. ↵
    1. Dodge K &
    2. Scott JD

    2000 AKAP79 and the evolution of the AKAP model. FEBS Letters 476 58–61.
31. ↵
    1. Dodge KL,
    2. Khouangsathiene S,
    3. Kapiloff MS,
    4. Mouton R,
    5. Hill EV,
    6. Houslay MD,
    7. Langeberg LK &
    8. Scott JD

    2001 mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO Journal 20 1921–1930.
32. ↵
    1. Dodge-Kafka KL,
    2. Soughayer J,
    3. Pare GC,
    4. Carlisle Michel JJ,
    5. Langeberg LK,
    6. Kapiloff MS &
    7. Scott JD

    2005 The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437 574–578.
33. ↵
    1. Dostmann WR &
    2. Taylor SS

    1991 Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I. Biochemistry 30 8710–8716.
34. ↵
    1. Feliciello A,
    2. Gottesman ME &
    3. Avvedimento EV

    2001 The biological functions of A-kinase anchor proteins. Journal of Molecular Biology 308 99–114.
35. ↵
    1. Fraser ID &
    2. Scott JD

    1999 Modulation of ion channels: a “current” view of AKAPs. Neuron 23 423–426.
36. ↵
    1. Fraser ID,
    2. Tavalin SJ,
    3. Lester LB,
    4. Langeberg LK,
    5. Westphal AM,
    6. Dean RA,
    7. Marrion NV &
    8. Scott JD

    1998 A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO Journal 17 2261–2272.
37. ↵
    1. Gamm DM,
    2. Baude EJ &
    3. Uhler MD

    1996 The major catalytic subunit isoforms of cAMP-dependent protein kinase have distinct biochemical properties in vitro and in vivo. Journal of Biological Chemistry 271 15736–15742.
38. ↵
    1. Gao T,
    2. Yatani A,
    3. Dell'Acqua ML,
    4. Sako H,
    5. Green SA,
    6. Dascal N,
    7. Scott JD &
    8. Hosey MM

    1997 cAMP-dependent regulation of cardiac L-type Ca²⁺ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 1 185–196.
39. ↵
    1. Gardner LA,
    2. Tavalin SJ,
    3. Goehring AS,
    4. Scott JD &
    5. Bahouth SW

    2006 AKAP79-mediated targeting of the cyclic AMP-dependent protein kinase to the beta1-adrenergic receptor promotes recycling and functional resensitization of the receptor. Journal of Biological Chemistry 281 33537–33553.
40. ↵
    1. Gold MG,
    2. Lygren B,
    3. Dokurno P,
    4. Hoshi N,
    5. McConnachie G,
    6. Tasken K,
    7. Carlson CR,
    8. Scott JD &
    9. Barford D

    2006 Molecular basis of AKAP specificity for PKA regulatory subunits. Molecular Cell 24 383–395.
41. ↵
    1. Gray PC,
    2. Johnson BD,
    3. Westenbroek RE,
    4. Hays LG,
    5. Yates JR III.,
    6. Scheuer T,
    7. Catterall WA &
    8. Murphy BJ

    1998 Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron 20 1017–1026.
42. ↵
    1. Hall DD,
    2. Davare MA,
    3. Shi M,
    4. Allen ML,
    5. Weisenhaus M,
    6. McKnight GS &
    7. Hell JW

    2007 Critical role of cAMP-dependent protein kinase anchoring to the L-type calcium channel Cav1.2 via A-kinase anchor protein 150 in neurons. Biochemistry 46 1635–1646.
43. ↵
    1. Hanoune J &
    2. Defer N

    2001 Regulation and role of adenylyl cyclase isoforms. Annual Review of Pharmacology and Toxicology 41 145–174.
44. ↵
    1. Hausken ZE,
    2. Coghlan VM,
    3. Hastings CA,
    4. Reimann EM &
    5. Scott JD

    1994 Type II regulatory subunit (RII) of the cAMP-dependent protein kinase interaction with A-kinase anchor proteins requires isoleucines 3 and 5. Journal of Biological Chemistry 269 24245–24251.
45. ↵
    1. Hausken ZE,
    2. Dell'Acqua ML,
    3. Coghlan VM &
    4. Scott JD

    1996 Mutational analysis of the A-kinase anchoring protein (AKAP)-binding site on RII. Classification of side chain determinants for anchoring and isoform selective association with AKAPs. Journal of Biological Chemistry 271 29016–29022.
46. ↵
    1. Heller WT,
    2. Vigil D,
    3. Brown S,
    4. Blumenthal DK,
    5. Taylor SS &
    6. Trewhella J

    2004 C subunits binding to the protein kinase A RI alpha dimer induce a large conformational change. Journal of Biological Chemistry 279 19084–19090.
47. ↵
    1. Herberg FW,
    2. Maleszka A,
    3. Eide T,
    4. Vossebein L &
    5. Tasken K

    2000 Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding. Journal of Molecular Biology 298 329–339.
48. ↵
    1. Hoffmann R,
    2. Baillie GS,
    3. MacKenzie SJ,
    4. Yarwood SJ &
    5. Houslay MD

    1999 The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO Journal 18 893–903.
49. ↵
    1. Hoshi N,
    2. Zhang JS,
    3. Omaki M,
    4. Takeuchi T,
    5. Yokoyama S,
    6. Wanaverbecq N,
    7. Langeberg LK,
    8. Yoneda Y,
    9. Scott JD,
    10. Brown DA
    11. et al.

    2003 AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nature Neuroscience 6 564–571.
50. ↵
    1. Hoshi N,
    2. Langeberg LK &
    3. Scott JD

    2005 Distinct enzyme combinations in AKAP signalling complexes permit functional diversity. Nature Cell Biology 7 1066–1073.
51. ↵
    1. Hoshi N,
    2. Langeberg LK,
    3. Gould MC,
    4. Newton AC &
    5. Scott JD

    2010 Interaction with AKAP79 modifies the cellular pharmacology of PKC. Molecular Cell 37 541–550.
52. ↵
    1. Houslay MD &
    2. Adams DR

    2003 PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochemical Journal 370 1–18.
53. ↵
    1. Huang LJ,
    2. Durick K,
    3. Weiner JA,
    4. Chun J &
    5. Taylor SS

    1997a D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. PNAS 94 11184–11189.
54. ↵
    1. Huang LJ,
    2. Durick K,
    3. Weiner JA,
    4. Chun J &
    5. Taylor SS

    1997b Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. Journal of Biological Chemistry 272 8057–8064.
55. ↵
    1. Hulme JT,
    2. Lin TW,
    3. Westenbroek RE,
    4. Scheuer T &
    5. Catterall WA

    2003 Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15. PNAS 100 13093–13098.
56. ↵
    1. Jahnsen T,
    2. Hedin L,
    3. Lohmann SM,
    4. Walter U &
    5. Richards JS

    1986 The neural type II regulatory subunit of cAMP-dependent protein kinase is present and regulated by hormones in the rat ovary. Journal of Biological Chemistry 261 6637–6639.
57. ↵
    1. Jarnaess E &
    2. Tasken K

    2007 Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochemical Society Transactions 35 931–937.
58. ↵
    1. Jarnaess E,
    2. Ruppelt A,
    3. Stokka AJ,
    4. Lygren B,
    5. Scott JD &
    6. Tasken K

    2008 Dual specificity A-kinase anchoring proteins (AKAPs) contain an additional binding region that enhances targeting of protein kinase A type I. Journal of Biological Chemistry 283 33708–33718.
59. ↵
    1. Jarnaess E,
    2. Stokka AJ,
    3. Kvissel AK,
    4. Skalhegg BS,
    5. Torgersen KM,
    6. Scott JD,
    7. Carlson CR &
    8. Tasken K

    2009 Splicing factor arginine/serine-rich 17A (SFRS17A) is an A-kinase anchoring protein that targets protein kinase A to splicing factor compartments. Journal of Biological Chemistry 284 35154–35164.
60. ↵
    1. Kammerer S,
    2. Burns-Hamuro LL,
    3. Ma Y,
    4. Hamon C,
    5. Canaves JM,
    6. Shi MM,
    7. Nelson MR,
    8. Sing CF,
    9. Cantor CR,
    10. Taylor SS
    11. et al.

    2003 Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. PNAS 100 4066–4071.
61. ↵
    1. Kawasaki H,
    2. Springett GM,
    3. Mochizuki N,
    4. Toki S,
    5. Nakaya M,
    6. Matsuda M,
    7. Housman DE &
    8. Graybiel AM

    1998 A family of cAMP-binding proteins that directly activate Rap1. Science 282 2275–2279.
62. ↵
    1. Kinderman FS,
    2. Kim C,
    3. von Daake S,
    4. Ma Y,
    5. Pham BQ,
    6. Spraggon G,
    7. Xuong NH,
    8. Jennings PA &
    9. Taylor SS

    2006 A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase. Molecular Cell 24 397–408.
63. ↵
    1. Klauck TM,
    2. Faux MC,
    3. Labudda K,
    4. Langeberg LK,
    5. Jaken S &
    6. Scott JD

    1996 Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 271 1589–1592.
64. ↵
    1. Kopperud R,
    2. Christensen AE,
    3. Kjarland E,
    4. Viste K,
    5. Kleivdal H &
    6. Doskeland SO

    2002 Formation of inactive cAMP-saturated holoenzyme of cAMP-dependent protein kinase under physiological conditions. Journal of Biological Chemistry 277 13443–13448.
65. ↵
    1. Kuntziger T,
    2. Rogne M,
    3. Folstad RL &
    4. Collas P

    2006 Association of PP1 with its regulatory subunit AKAP149 is regulated by serine phosphorylation flanking the RVXF motif of AKAP149. Biochemistry 45 5868–5877.
66. ↵
    1. Lee DC,
    2. Carmichael DF,
    3. Krebs EG &
    4. McKnight GS

    1983 Isolation of a cDNA clone for the type I regulatory subunit of bovine cAMP-dependent protein kinase. PNAS 80 3608–3612.
67. ↵
    1. Leon DA,
    2. Herberg FW,
    3. Banky P &
    4. Taylor SS

    1997 A stable alpha-helical domain at the N terminus of the RIalpha subunits of cAMP-dependent protein kinase is a novel dimerization/docking motif. Journal of Biological Chemistry 272 28431–28437.
68. ↵
    1. Lugnier C

    2006 Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacology and Therapeutics 109 366–398.
69. ↵
    1. Lygren B,
    2. Carlson CR,
    3. Santamaria K,
    4. Lissandron V,
    5. McSorley T,
    6. Litzenberg J,
    7. Lorenz D,
    8. Wiesner B,
    9. Rosenthal W,
    10. Zaccolo M
    11. et al.

    2007 AKAP complex regulates Ca²⁺ re-uptake into heart sarcoplasmic reticulum. EMBO Reports 8 1061–1067.
70. ↵
    1. Michel JJ &
    2. Scott JD

    2002 AKAP mediated signal transduction. Annual Review of Pharmacology and Toxicology 42 235–257.
71. ↵
    1. Nakamura T &
    2. Gold GH

    1987 A cyclic nucleotide-gated conductance in olfactory receptor cilia. Nature 325 442–444.
72. ↵
    1. Navedo MF,
    2. Nieves-Cintrón M,
    3. Amberg GC,
    4. Yuan C,
    5. Votaw VS,
    6. Lederer WJ,
    7. McKnight GS &
    8. Santana LF

    2008 AKAP150 is required for stuttering persistent Ca2+ sparklets and angiotensin II-induced hypertension. Circulation research 102 e1–e11.
73. ↵
    1. Newhall KJ,
    2. Criniti AR,
    3. Cheah CS,
    4. Smith KC,
    5. Kafer KE,
    6. Burkart AD &
    7. McKnight GS

    2006 Dynamic anchoring of PKA is essential during oocyte maturation. Current Biology 16 321–327.
74. ↵
    1. Newlon MG,
    2. Roy M,
    3. Morikis D,
    4. Hausken ZE,
    5. Coghlan V,
    6. Scott JD &
    7. Jennings PA

    1999 The molecular basis for protein kinase A anchoring revealed by solution NMR. Nature Structural and Molecular Biology 6 222–227.
75. ↵
    1. Newlon MG,
    2. Roy M,
    3. Morikis D,
    4. Carr DW,
    5. Westphal R,
    6. Scott JD &
    7. Jennings PA

    2001 A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. EMBO Journal 20 1651–1662.
76. ↵
    1. Potter RL &
    2. Taylor SS

    1979 Relationships between structural domains and function in the regulatory subunit of cAMP-dependent protein kinases I and II from porcine skeletal muscle. Journal of Biological Chemistry 254 2413–2418.
77. ↵
    1. Reimann EM,
    2. Walsh DA &
    3. Krebs EG

    1971 Purification and properties of rabbit skeletal muscle adenosine 3′,5′-monophosphate-dependent protein kinases. Journal of Biological Chemistry 246 1986–1995.
78. ↵
    1. Rosenmund C,
    2. Carr DW,
    3. Bergeson SE,
    4. Nilaver G,
    5. Scott JD &
    6. Westbrook GL

    1994 Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 368 853–856.
79. ↵
    1. Ruppelt A,
    2. Mosenden R,
    3. Gronholm M,
    4. Aandahl EM,
    5. Tobin D,
    6. Carlson CR,
    7. Abrahamsen H,
    8. Herberg FW,
    9. Carpen O &
    10. Tasken K

    2007 Inhibition of T cell activation by cyclic adenosine 5′-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin. Journal of Immunology 179 5159–5168.
80. ↵
    Ruppelt A, Oberprieler NG, Magklaras G & Tasken K 2009 Physiological substrates of PKA and PKG. In Handbook of Cellular Signalling, Ed R. Bradshaw. Part II: Transmission: Effectors and Cytosolic Events, Ed Tony Hunter. Subsection F: Cyclic Nucleotides, Ed J. Corbin. vol 183, pp 1497–1514. La Jolla, CA: Academic Press.
81. ↵
    1. Saotome I,
    2. Curto M &
    3. McClatchey AI

    2004 Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Developmental cell 6 855–864.
82. ↵
    1. Schillace RV &
    2. Scott JD

    1999 Association of the type 1 protein phosphatase PP1 with the A-kinase anchoring protein AKAP220. Current Biology 9 321–324.
83. ↵
    1. Scott JD

    1991 Cyclic nucleotide-dependent protein kinases. Pharmacology and Therapeutics 50 123–145.
84. ↵
    1. Scott JD &
    2. Pawson T

    2009 Cell signaling in space and time: where proteins come together and when they're apart. Science 326 1220–1224.
85. ↵
    1. Scott JD,
    2. Glaccum MB,
    3. Zoller MJ,
    4. Uhler MD,
    5. Helfman DM,
    6. McKnight GS &
    7. Krebs EG

    1987 The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain. PNAS 84 5192–5196.
86. ↵
    1. Shabb JB

    2001 Physiological substrates of cAMP-dependent protein kinase. Chemical Reviews 101 2381–2411.
87. ↵
    1. Skalhegg BS &
    2. Tasken K

    2000 Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Frontiers in Bioscience 5 D678–D693.
88. ↵
    1. Soderling SH,
    2. Langeberg LK,
    3. Soderling JA,
    4. Davee SM,
    5. Simerly R,
    6. Raber J &
    7. Scott JD

    2003 Loss of WAVE-1 causes sensorimotor retardation and reduced learning and memory in mice. PNAS 100 1723–1728.
89. ↵
    1. Steen RL,
    2. Martins SB,
    3. Tasken K &
    4. Collas P

    2000 Recruitment of protein phosphatase 1 to the nuclear envelope by A-kinase anchoring protein AKAP149 is a prerequisite for nuclear lamina assembly. Journal of Cell Biology 150 1251–1262.
90. ↵
    1. Tasken K &
    2. Aandahl EM

    2004 Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiological Reviews 84 137–167.
91. ↵
    1. Tasken K,
    2. Skalhegg BS,
    3. Solberg R,
    4. Andersson KB,
    5. Taylor SS,
    6. Lea T,
    7. Blomhoff HK,
    8. Jahnsen T &
    9. Hansson V

    1993 Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RI alpha-RI beta heterodimeric complexes. Journal of Biological Chemistry 268 21276–21283.
92. ↵
    1. Tasken KA,
    2. Collas P,
    3. Kemmner WA,
    4. Witczak O,
    5. Conti M &
    6. Tasken K

    2001 Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area. Journal of Biological Chemistry 276 21999–22002.
93. ↵
    1. Taylor SS,
    2. Kim C,
    3. Cheng CY,
    4. Brown SH,
    5. Wu J &
    6. Kannan N

    2008 Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochimica et Biophysica Acta 1784 16–26.
94. ↵
    1. Torheim EA,
    2. Jarnaess E,
    3. Lygren B &
    4. Tasken K

    2009 Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling. Biochemical Journal 424 69–78.
95. ↵
    1. Trotter KW,
    2. Fraser ID,
    3. Scott GK,
    4. Stutts MJ,
    5. Scott JD &
    6. Milgram SL

    1999 Alternative splicing regulates the subcellular localization of A-kinase anchoring protein 18 isoforms. Journal of Cell Biology 147 1481–1492.
96. ↵
    1. Tunquist BJ,
    2. Hoshi N,
    3. Guire ES,
    4. Zhang F,
    5. Mullendorff K,
    6. Langeberg LK,
    7. Raber J &
    8. Scott JD

    2008 Loss of AKAP150 perturbs distinct neuronal processes in mice. PNAS 105 12557–12562.
97. ↵
    1. Vigil D,
    2. Blumenthal DK,
    3. Heller WT,
    4. Brown S,
    5. Canaves JM,
    6. Taylor SS &
    7. Trewhella J

    2004 Conformational differences among solution structures of the type Iα, IIα and IIβ protein kinase. A regulatory subunit homodimers: role of the linker regions. Journal of Molecular Biology 337 1183–1194.
98. ↵
    1. Vigil D,
    2. Blumenthal DK,
    3. Taylor SS &
    4. Trewhella J

    2005 The conformationally dynamic C helix of the RIα subunit of protein kinase A mediates isoform-specific domain reorganization upon C subunit binding. Journal of Biological Chemistry 280 35521–35527.
99. ↵
    1. Vigil D,
    2. Blumenthal DK,
    3. Taylor SS &
    4. Trewhella J

    2006 Solution scattering reveals large differences in the global structures of type II protein kinase A isoforms. Journal of Molecular Biology 357 880–889.
100. ↵
     1. Walsh DA,
     2. Perkins JP &
     3. Krebs EG

     1968 An adenosine 3′,5′-monophosphate-dependant protein kinase from rabbit skeletal muscle. Journal of Biological Chemistry 243 3763–3765.
101. ↵
     1. Wirtenberger M,
     2. Schmutzhard J,
     3. Hemminki K,
     4. Meindl A,
     5. Sutter C,
     6. Schmutzler RK,
     7. Wappenschmidt B,
     8. Kiechle M,
     9. Arnold N,
     10. Weber BH
     11. et al.

     2007 The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer. Carcinogenesis 28 423–426.
102. ↵
     1. Wong W &
     2. Scott JD

     2004 AKAP signalling complexes: focal points in space and time. Nature Reviews. Molecular Cell Biology 5 959–970.
103. ↵
     1. Yang Y,
     2. Mahaffey CL,
     3. Berube N &
     4. Frankel WN

     2006 Interaction between fidgetin and protein kinase A-anchoring protein AKAP95 is critical for palatogenesis in the mouse. Journal of Biological Chemistry 281 22352–22359.
104. ↵
     1. Zaccolo M &
     2. Pozzan T

     2002 Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295 1711–1715.
105. ↵
     1. Zaccolo M,
     2. Magalhaes P &
     3. Pozzan T

     2002 Compartmentalisation of cAMP and Ca(2+) signals. Current Opinion in Cell Biology 14 160–166.
106. ↵
     1. Zhao J,
     2. Hoye E,
     3. Boylan S,
     4. Walsh DA &
     5. Trewhella J

     1998 Quaternary structures of a catalytic subunit-regulatory subunit dimeric complex and the holoenzyme of the cAMP-dependent protein kinase by neutron contrast variation. Journal of Biological Chemistry 273 30448–30459.